Visalytics
Visalytics
approved EB-2 (NIW)

Fellow

Biomedical Science · Russia · 2025-02-10

Processing Time
287 days
Decision Date
2025-02-10
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in biomedical science with a focus on disease modeling, targeted therapy development, and the molecular characterization of rare tumors. The work involves genomic analysis of pediatric and adult tumors to enable personalized treatments and validate the effectiveness of drugs like seribantumab and zenocutuzumab. The intended impact is to address urgent gaps in oncology and overcome drug resistance mechanisms in under-researched cancers.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses urgent gaps in oncology and the development of therapeutic strategies for rare cancers, which is a national health priority.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 30 publications, high citation count, and NIH funding demonstrates a strong track record of success in the field.

3 On Balance, Beneficial to Waive Job Offer Met

The petitioner's unique expertise in rare tumor genomics provides a significant benefit to U.S. medical innovation that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 30 peer-reviewed journal articles, 32 scientific abstracts, and over 1,000 citations from researchers in 49 countries. Evidence included an h-index of 13, 15 peer reviews for high-impact journals, and funding support from the National Institutes of Health (NIH). The case successfully satisfied all three Dhanasar prongs by demonstrating the national importance of oncology research and the petitioner's established expertise.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
69 days 2026-01-26
The petitioner proposes to continue research on elucidating molecular mechanisms and identifying novel therapeutics for rare and advanced metastatic cancers. The work involves using cell-based assays, advanced biotechnological approaches, and computer-aided drug design to advance personalized medicine and improve patient survival outcomes.
View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Research Scientist

Healthcare · Vietnam

WeGreened EB-2 (NIW) rfe approved
297 days 2025-01-11
The petitioner proposes to continue her research in medical science by investigating molecular pathways involved in tumor proliferation. Her work focuses on developing targeted inhibitors and antibodies designed to slow or prevent cancer progression and improve patient monitoring in clinical settings.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Russia

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-10.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 287 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Russia All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist